Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | RAD51D |
Variant | G258Sfs*50 |
Impact List | frameshift |
Protein Effect | unknown |
Gene Variant Descriptions | RAD51D G258Sfs*50 indicates a shift in the reading frame starting at amino acid 258 and terminating 50 residues downstream causing a premature truncation of the 328 amino acid Rad51d protein (UniProt.org). G258Sfs*50 has been identified in the scientific literature (PMID: 28588062), but has not been biochemically characterized and therefore, its effect on Rad51d protein function is unknown (PubMed, Jun 2024). |
Associated Drug Resistance | |
Category Variants Paths |
RAD51D mutant RAD51D G258Sfs*50 |
Transcript | NM_002878.4 |
gDNA | chr17:g.(35101016_35101332) |
cDNA | c.(772_924) |
Protein | p.G258Sfs*50 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_002878.3 | chr17:g.(35101016_35101332) | c.(772_924) | p.G258Sfs*50 | RefSeq | GRCh38/hg38 |
NM_002878 | chr17:g.(35101016_35101332) | c.(772_924) | p.G258Sfs*50 | RefSeq | GRCh38/hg38 |
NM_002878.4 | chr17:g.(35101016_35101332) | c.(772_924) | p.G258Sfs*50 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
RAD51D G258Sfs*50 | ovarian carcinoma | sensitive | Rucaparib | Preclinical - Cell culture | Actionable | In a clinical study, an ovarian carcinoma patient harboring a RAD51D G258Sfs*50 germline mutation demonstrated stable disease when treated with Rubraca (rucaparib) (PMID: 28588062). | 28588062 |